Oramed Pharmaceuticals, Inc. (ORMP)
5.24
+0.03
(+0.58%)
USD |
NASDAQ |
Aug 26, 13:05
Oramed Pharmaceuticals Total Liabilities (Quarterly) : 52.17M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.17M |
| March 31, 2026 | 30.57M |
| December 31, 2025 | 31.12M |
| September 30, 2025 | 18.16M |
| June 30, 2025 | 8.101M |
| March 31, 2025 | 7.645M |
| December 31, 2024 | 9.931M |
| September 30, 2024 | 9.559M |
| June 30, 2024 | 8.069M |
| March 31, 2024 | 37.93M |
| December 31, 2023 | 57.66M |
| September 30, 2023 | 82.66M |
| June 30, 2023 | 5.659M |
| March 31, 2023 | 9.632M |
| December 31, 2022 | 10.49M |
| September 30, 2022 | 11.29M |
| June 30, 2022 | 9.254M |
| March 31, 2022 | 10.00M |
| August 31, 2021 | 11.48M |
| May 31, 2021 | 11.30M |
| February 28, 2021 | 12.22M |
| November 30, 2020 | 12.76M |
| August 31, 2020 | 11.75M |
| May 31, 2020 | 12.04M |
| February 29, 2020 | 13.79M |
| Date | Value |
|---|---|
| November 30, 2019 | 13.98M |
| August 31, 2019 | 15.27M |
| May 31, 2019 | 15.88M |
| February 28, 2019 | 16.46M |
| November 30, 2018 | 14.74M |
| August 31, 2018 | 16.28M |
| May 31, 2018 | 18.00M |
| February 28, 2018 | 17.77M |
| November 30, 2017 | 18.80M |
| August 31, 2017 | 19.47M |
| May 31, 2017 | 19.98M |
| February 28, 2017 | 20.51M |
| November 30, 2016 | 20.94M |
| August 31, 2016 | 16.64M |
| May 31, 2016 | 5.322M |
| February 29, 2016 | 5.667M |
| November 30, 2015 | 1.342M |
| August 31, 2015 | 1.526M |
| May 31, 2015 | 0.802M |
| February 28, 2015 | 0.641M |
| November 30, 2014 | 0.863M |
| August 31, 2014 | 1.009M |
| May 31, 2014 | 0.527M |
| February 28, 2014 | 0.3822M |
| November 30, 2013 | 0.7004M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 108.40B |
| Pfizer Inc. | 115.64B |
| Yarrow Bioscience, Inc. | 1.542M |
| Liquidia Corp. | 326.80M |
| NRX Pharmaceuticals, Inc. | 34.33M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 369.64M |
| Shareholders Equity (Quarterly) | 317.47M |
| Debt to Equity Ratio | 0.0023 |
| Current Ratio | 4.977 |
| Net Debt Paydown Yield | -0.04% |